Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on Offer for Subscription

22 Jun 2021 17:22

RNS Number : 7588C
Amati AIM VCT PLC
22 June 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

AMATI AIM VCT PLC

LEI: 213800HAEDBBK9RWCD25

22 June 2021

Update on Offer for Subscription

Following the announcement made on 12 April 2021, the Board of Amati AIM VCT PLC (the "Company") has discussed the size and structure of the proposed offer for subscription (the "Offer") with the Company's investment manager. Having considered the deployment of funds over the last six months and the current pipeline of investment opportunities, the Company is seeking to raise £30 million over a 12 month period from the date of publication of the prospectus related to the Offer. Initially, subscriptions will be accepted for the 2021/2022 tax year only.

The Directors will also have discretion to utilise an over-allotment facility of up to £30 million, either in whole or in part. This facility will only be utilised if sufficient Qualifying Investments have been made from the initial proceeds of the Offer and the investment manager has identified further investment opportunities. In this event, the Company may also accept applications in respect of the 2022/2023 tax year.

Subject to certain conditions, the Board intends to open the Offer to existing shareholders for a limited period prior to opening the Offer to new investors.

The prospectus, which will contain the full details and terms and conditions of the Offer, will be available from www.amatiglobal.com as soon as the Offer is launched, which is expected to be at the end of July 2021. A further announcement will be made when the prospectus is available.

Further information

For further information please contact Samantha Dalby on 0131 503 9115 or email: info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKKAAFXFEFA
Date   Source Headline
11th Mar 20223:13 pmRNSNet Asset Value(s)
11th Mar 202211:52 amRNSCompliance with Market Abuse Regulation
4th Mar 20224:16 pmRNSNet Asset Value(s)
2nd Mar 20225:05 pmRNSDirector/PDMR Shareholding
2nd Mar 20224:58 pmRNSIssue of Equity
2nd Mar 20222:00 pmRNSResult of General Meeting
1st Mar 20225:37 pmRNSNet Asset Value(s)
1st Mar 202211:43 amRNSTotal Voting Rights
21st Feb 20224:57 pmRNSTransaction in Own Shares
21st Feb 20228:53 amRNSClose of Offer to Further Applications
18th Feb 20223:34 pmRNSNet Asset Value(s)
14th Feb 20224:06 pmRNSTransaction in Own Shares
14th Feb 20229:27 amRNSUpdate on offer for subscription
11th Feb 20224:41 pmRNSNet Asset Value(s)
7th Feb 20225:25 pmRNSTransaction in Own Shares
7th Feb 20221:15 pmRNSCircular Publication & Notice of General Meeting
4th Feb 20224:00 pmRNSNet Asset Value per Share
2nd Feb 202212:04 pmRNSNet Asset Value(s)
1st Feb 20229:51 amRNSTotal Voting Rights
24th Jan 202212:30 pmRNSTransaction in Own Shares
21st Jan 20226:16 pmRNSNet Asset Value per Share
21st Jan 20222:12 pmRNSTransaction in Own Shares
18th Jan 20221:47 pmRNSPublication of a supplementary Prospectus
18th Jan 202212:49 pmRNSTransaction in Own Shares
17th Jan 20227:00 amRNSNet Asset Value per Share
12th Jan 20221:08 pmRNSTransaction in Own Shares
7th Jan 20226:27 pmRNSNet Asset Value per Share
6th Jan 20221:45 pmRNSTransaction in Own Shares
4th Jan 20225:14 pmRNSNet Asset Value(s)
29th Dec 20217:00 amRNSNet Asset Value(s)
17th Dec 20213:54 pmRNSNet Asset Value(s)
15th Dec 20217:00 amRNSUpdate on Offer for Subscription
13th Dec 20218:43 amRNSNet Asset Value(s)
2nd Dec 20218:03 amRNSNet Asset Value(s)
1st Dec 202111:25 amRNSTotal Voting Rights
30th Nov 20211:04 pmRNSDirector/PDMR Shareholding
26th Nov 20214:09 pmRNSIssue of Equity - DRIS
26th Nov 20212:03 pmRNSPurchase of Own Securities
26th Nov 20211:50 pmRNSNet Asset Value(s)
24th Nov 202110:23 amRNSTransaction in Own Shares
22nd Nov 20219:19 amRNSTransaction in Own Shares
19th Nov 20213:38 pmRNSNet Asset Value(s)
12th Nov 20213:20 pmRNSNet Asset Value(s)
5th Nov 20213:58 pmRNSNet Asset Value(s)
3rd Nov 20219:18 amRNSTransaction in Own Shares
1st Nov 20214:54 pmRNSNet Asset Value(s)
1st Nov 20212:24 pmRNSTransaction in Own Shares
1st Nov 202110:23 amRNSTotal Voting Rights
25th Oct 202110:21 amRNSNet Asset Value(s)
15th Oct 20214:25 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.